-transparent.png){kind=logo}
The antibody-coated bacteria (ACB) test was used to localize the site of urinary tract infection in a group of pediatric and adult patients. Duration of treatment of ACB-positive (upper tract) and ACB-negative (lower tract) infections was correlated with rates of recurrence during follow-up for six or more months. Two relapses with the same organism occurred after 29 ACB-negative episodes were treated with a short course of antimicrobials (less than or equal to 14 days). Of patients with ACB-positive infections, all four given similar short-duration therapy experienced relapse with the same organism, but none of nine had relapse after long-duration therapy (greater than or equal to 28 days). High cure rates were obtained with less than or equal to 14 days therapy in ACB-negative infections and with greater than or equal to 28 days therapy in ACB-positive cases. The ACB test promises to be useful in predicting the appropriate duration of antibiotic therapy.
H P Kulasinghe, and
A H Cushing, and
W P Reed
January 1982,
Kidney international,
H P Kulasinghe, and
A H Cushing, and
W P Reed
July 1982,
Casopis lekaru ceskych,
H P Kulasinghe, and
A H Cushing, and
W P Reed
January 1988,
Archives de l'Institut Pasteur d'Algerie. Institut Pasteur d'Algerie,
H P Kulasinghe, and
A H Cushing, and
W P Reed
December 1978,
Kidney international,
H P Kulasinghe, and
A H Cushing, and
W P Reed
October 1978,
Mayo Clinic proceedings,
H P Kulasinghe, and
A H Cushing, and
W P Reed
September 1976,
Acta paediatrica Scandinavica,
H P Kulasinghe, and
A H Cushing, and
W P Reed
August 1975,
Kidney international. Supplement,
H P Kulasinghe, and
A H Cushing, and
W P Reed
December 1979,
Lancet (London, England),
H P Kulasinghe, and
A H Cushing, and
W P Reed
March 1979,
The Journal of pediatrics,
H P Kulasinghe, and
A H Cushing, and
W P Reed
August 1980,
Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete,
